WESPAC Advisors SoCal’s Celgene Corp CELG Stock Holding History

WESPAC Advisors SoCal’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$8K	–	386
2018 Q3	$8K	Buy	+100	New	+$8.84K	﹤0.01%	252
2018 Q1	–	Sell	-6,225	Closed	-$649K	–	313
2017 Q4	$649K	Buy	+6,225	New	+$702K	0.37%	49
2016 Q4	–	Sell	-44	Closed	-$4.6K	–	300
2016 Q3	$4.6K	Buy	+44	New	+$4.76K	﹤0.01%	225
2016 Q1	–	Sell	-6,280	Closed	-$752K	–	340
2015 Q4	$752K	Buy	+6,280	New	+$727K	0.5%	39

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WESPAC Advisors SoCal's CELG Position: Q4 2018 in Review

WESPAC Advisors SoCal sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 100 shares — an estimated $8K sold.

WESPAC Advisors SoCal first reported a position in CELG in Q4 2015 and held it in 4 quarters. The position peaked at $752K in Q4 2015. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

WESPAC Advisors SoCal reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
WESPAC Advisors SoCal sold 100 Celgene Corp shares in Q4 2018, an estimated $8K.
WESPAC Advisors SoCal first reported a position in Celgene Corp in Q4 2015 and held it in 4 quarters.
WESPAC Advisors SoCal's Celgene Corp position peaked at $752K in Q4 2015.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on WESPAC Advisors SoCal's 13F filing for Q4 2018, filed 7 Feb 2019.